Drug
Carbidopa Levodopa Entacapone
Carbidopa Levodopa Entacapone: highest development phase Post-Market, developed by Novartis. 2 trial records tracked on RxWires.
- Highest phase
- Post-Market
- Developer
- Novartis
Trials
| Drug | Phase | Indication |
|---|---|---|
| Carbidopa/levodopa/entacapone NCT00642356 | Post-Market | Parkinson's Disease |
| Carbidopa/levodopa/entacapone NCT00099268 | Phase 3 | Parkinson's Disease |
Latest
No recent events.
Follow Carbidopa Levodopa Entacapone on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.